Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe revision label in the study documents section was updated from v3.6.0 to v3.6.3, indicating a newer version of the protocol/document referenced on the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page gains new navigation items such as No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, along with a revision tag for v3.6.0. The older heading Intervention / Treatment and the v3.5.5 revision were removed.SummaryDifference0.4%

- Check24 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now displays Revision: v3.5.4 in place of Revision: v3.5.3, indicating a new site software release. This update affects page labeling but not the underlying study information.SummaryDifference0.0%

- Check67 days agoChange DetectedThis updates the page’s revision/version label from **v3.5.2** to **v3.5.3** in the footer, indicating a minor site maintenance change rather than a change to the underlying trial information.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded revision: v3.5.2. Removed revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.